Venture Capital For Life Sciences companies

Global Investments in compelling Biotech and Med-Tech discoveries.

Epidarex is a transatlantic venture capital firm led by a diverse team of early-stage investors building breakthrough life science companies in emerging hubs.

We're sophisticated managers of a life sciences venture capital fund.

GGC is an early stage venture capital firm known for its exceptional expertise in finding, cultivating and assessing complex science and technology start-ups.

Unlocking potential in life sciences.

Life extension for People and Planet. We invest where AI meets science.

A hands-on approach to biotech incubation.

We invest in and develop the most innovative early-stage startups in life sciences in Europe.

Pappas Capital invests exclusively in the life science sector.

Martlet Capital is an early-stage investor, providing patient capital to deep technology and life science startups.

Identifying true innovations and building ambitious companies.

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

We're biomedical researchers investing in a new generation of translational founders.

Accelerating the future of healthcare. KHP Ventures is a collaboration between King’s College London, King’s College Hospital NHS Foundation Trust and Guy’s and…

Investing in disruptive, early-stage biopharma companies across Europe.

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.

A leading European Venture Capital firm investing in early- and growth-stage Life Science companies.

Bold bets on science.

Samsara BioCapital was founded after years of working in the medical field and investment industry.

Rex Health Ventures (RHV) enables groundbreaking work by investing in and fostering companies and technologies that advance the future of health.